GO:1990742 microvesicle: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990742 microvesicle describes an extracellular vesicle released from the plasma membrane, ranging from about 100 nm to 1000 nm.
• Microvesicles are distinct from exosomes in their biogenesis, size, and membrane origin, and are also called ectosomes or shedding vesicles.
• Microvesicle release is driven by cytoskeletal remodeling, calcium signaling, and membrane phospholipid redistribution.
• Microvesicles carry proteins, lipids, RNA, and mitochondria that can reprogram recipient cells in sepsis, cancer, and cardiovascular disease.
• Key molecular regulators include ARF6, RhoA, ROCK, flippase/floppase enzymes, and ESCRT-associated proteins.
• Microvesicles are promising biomarkers and therapeutic targets, and CRISPR-based models enable causal dissection of their biogenesis genes.
Description
Microvesicles (GO:1990742) are extracellular vesicles that bud directly from the plasma membrane and range in size from approximately 100 nm to 1000 nm. They are also known as ectosomes, extracellular microvesicles, or shedding vesicles, and they differ from exosomes in both biogenesis and physical properties. Because microvesicles carry bioactive cargo such as proteins, lipids, RNA, and even mitochondria, they function as intercellular communication vehicles in physiology and disease. Understanding microvesicle biology is therefore central to fields as diverse as cancer, infection, cardiovascular medicine, and immunology. Researchers study microvesicles to identify biomarkers, to understand how cells respond to stress, and to develop vesicle-based therapeutics. The QuickGO definition provides a precise anchor: an extracellular vesicle released from the plasma membrane and ranging in size from about 100 nm to 1000 nm. This article synthesizes authoritative ontology data and verified PubMed literature to explain microvesicle components, assembly, regulation, disease relevance, and research methods.
microvesicle At A Glance
| GO ID | GO:1990742 |
|---|---|
| GO term | microvesicle |
| Ontology | cellular_component |
| Synonym | ectosome, extracellular microvesicle, shedding vesicle |
| Definition | An extracellular vesicle released from the plasma membrane and ranging in size from about 100 nm to 1000 nm. |
| Size range | Approximately 100 nm to 1000 nm |
| Origin | Plasma membrane |
| Major function | Intercellular communication via transfer of proteins, lipids, RNA, and organelles |
| Related process | Vesicle biogenesis, membrane budding, cytoskeletal remodeling |
What Is GO:1990742?
GO:1990742 microvesicle is a cellular component term describing an extracellular vesicle that is released from the plasma membrane and ranges in size from about 100 nm to 1000 nm. In contrast to exosomes, which originate from endosomal multivesicular bodies, microvesicles form by outward budding and fission of the plasma membrane. The term encompasses synonyms such as ectosome, extracellular microvesicle, and shedding vesicle. Microvesicles are defined by their membrane origin, size range, and extracellular release, and they can be distinguished experimentally from other extracellular vesicles by these criteria.
Why Is microvesicle Important in Cell Biology?
Microvesicles are important because they mediate intercellular communication in both health and disease, transferring proteins, lipids, RNA, and even mitochondria between cells. Their release is dynamically regulated by triggers such as calcium influx, shear stress, and inflammatory signals, and their cargo can reprogram recipient cells. In cancer, microvesicles contribute to multidrug resistance and tumor progression. In sepsis, microvesicle-transferred mitochondria can trigger cGAS-STING signaling and metabolic reprogramming in macrophages. In cardiovascular disease, microvesicle release and clearance influence thrombosis and inflammation. Because microvesicles are accessible in body fluids, they are attractive biomarkers and therapeutic vehicles.
• Microvesicles mediate intercellular transfer of proteins, lipids, RNA, and mitochondria.
• They are released from the plasma membrane in a calcium- and cytoskeleton-dependent manner.
• Microvesicles contribute to cancer multidrug resistance and tumor progression.
• They play a role in Shiga toxin-associated infection and bacterial pathogenesis.
• Microvesicle-transferred mitochondria trigger cGAS-STING and metabolic reprogramming in sepsis.
• Dynamic microvesicle release and clearance regulate cardiovascular homeostasis and thrombosis.
• Microvesicle release drives mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction.
• Microvesicle-eluting implants can modulate inflammatory responses of keratinocytes.
• Microvesicles are promising biomarkers for disease diagnosis and prognosis.
• CRISPR-based models enable causal testing of microvesicle biogenesis genes.
Microvesicle Biology: Biogenesis, Structure, and Molecular Mechanism
Initiation and Plasma Membrane Budding
In simple terms: Microvesicles start to form when the cell membrane bulges outward.
Microvesicle biogenesis begins with outward budding of the plasma membrane, a process triggered by calcium influx, cytoskeletal remodeling, and phospholipid redistribution. Calcium-dependent enzymes such as flippases and floppases alter membrane asymmetry, while Rho GTPases and their effectors promote actin reorganization. These events create a bud that eventually pinches off as a microvesicle.
Cargo Selection and Packaging
In simple terms: Cells pack specific molecules into microvesicles before they are released.
Microvesicles selectively package proteins, lipids, RNA, and even mitochondria, depending on the cell type and physiological state. Cargo selection involves interactions with membrane microdomains, ESCRT-associated proteins, and cytoskeletal adaptors. For example, microvesicle-transferred mitochondria can be delivered to macrophages and trigger cGAS-STING signaling.
Release and Clearance
In simple terms: Once formed, microvesicles are released into the extracellular space and eventually cleared.
Microvesicle release is a dynamic process regulated by triggers such as shear stress, inflammation, and coagulation factors. After release, microvesicles can be cleared from circulation by phagocytes or taken up by recipient cells. In cardiovascular system, microvesicle release and clearance are balanced to maintain homeostasis.
Uptake and Functional Reprogramming
In simple terms: Recipient cells take up microvesicles and change their behavior.
Microvesicles can fuse with or be internalized by recipient cells, delivering their cargo and reprogramming cellular functions. In sepsis, microvesicle-transferred mitochondria reprogram macrophage metabolism via cGAS-STING. In cancer, microvesicles can promote multidrug resistance by transferring resistance-associated proteins.
Regulation by Mechanical and Inflammatory Signals
In simple terms: Physical forces and inflammation control how many microvesicles are made.
Mechanobiology studies show that shear stress and membrane tension regulate microvesicle release, uptake, and microvesicle-mediated activation. Inflammatory stimuli also enhance microvesicle production, as seen in sepsis and cardiovascular disease. These regulatory inputs make microvesicle release a responsive, context-dependent process.
Key Genes Involved in GO:1990742 microvesicle
The following genes and proteins are experimentally implicated in microvesicle biogenesis, cargo selection, release, or function according to verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ARF6 | Promotes plasma membrane budding and microvesicle release | Target for studying microvesicle biogenesis |
| RhoA | Regulates actin cytoskeleton during microvesicle shedding | Key regulator of microvesicle release |
| ROCK | Effector of RhoA that controls actomyosin contraction | Modulates microvesicle budding |
| ESCRT components | Mediate membrane scission and cargo sorting | Implicated in microvesicle biogenesis |
| Flippase/floppase enzymes | Regulate phospholipid asymmetry | Control membrane curvature for microvesicle formation |
| cGAS | Senses microvesicle-transferred mitochondrial DNA | Mediates inflammatory signaling in sepsis |
| STING | Adaptor in cGAS-STING pathway | Links microvesicles to innate immunity |
| P2X7 receptor | Calcium influx trigger for microvesicle release | Studied in inflammation and cardiovascular disease |
| Annexin A1 | Calcium-dependent membrane repair and vesicle release | Potential regulator of microvesicle shedding |
| Integrins | Mediate microvesicle adhesion and uptake | Important for cancer and cardiovascular microvesicle targeting |
| CD44 | Cell surface receptor involved in microvesicle uptake | Studied in cancer multidrug resistance |
| P-glycoprotein | Drug efflux pump transferred by microvesicles | Contributes to multidrug resistance |
| Mitochondria | Organelle cargo transferred by microvesicles | Triggers metabolic reprogramming in sepsis |
| Keratinocyte proteins | Respond to microvesicle-eluting implants | Model for inflammatory skin responses |
| Shiga toxin receptors | Mediate microvesicle involvement in infection | Studied in Shiga toxin-associated infection |
| Mitophagy regulators | Control mitochondrial quality control | Disrupted by microvesicles in sepsis-induced myocardial dysfunction |
How Is microvesicle Regulated?
Microvesicle release is regulated by calcium signaling, cytoskeletal dynamics, and inflammatory mediators. Mechanical forces such as shear stress modulate microvesicle release, uptake, and microvesicle-mediated activation. In the cardiovascular system, triggers and clearance mechanisms dynamically control microvesicle levels. In sepsis, microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in myocardial dysfunction. These regulatory pathways are potential targets for therapeutic intervention.
microvesicle and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARF6 | Cancer multidrug resistance | Knockout in cancer cell lines followed by microvesicle isolation |
| RhoA | Cancer progression and metastasis | Point mutation to test GTPase activity in microvesicle release |
| cGAS | Sepsis-induced inflammation | Knockout macrophages treated with microvesicles |
| STING | Sepsis and innate immunity | Knock-in reporter for cGAS-STING activation |
| P-glycoprotein | Multidrug resistance | Overexpression in drug-sensitive cells |
Microvesicles in Cancer and Multidrug Resistance
Microvesicles contribute to cancer progression and multidrug resistance by transferring proteins such as P-glycoprotein and CD44 to recipient cells. Proteins regulating microvesicle biogenesis are being investigated as biomarkers and therapeutic targets in oncology.
Microvesicles in Sepsis and Cardiovascular Disease
In sepsis, microvesicle-transferred mitochondria trigger cGAS-STING signaling and reprogram macrophage metabolism. Microvesicle release also drives mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction. In the cardiovascular system, dynamic microvesicle release and clearance influence thrombosis and inflammation.
Microvesicles in Infection and Inflammation
Microvesicles are involved in Shiga toxin-associated infection, where they can transfer toxins and modulate host responses. Microvesicle-eluting nano-engineered implants influence inflammatory responses of keratinocytes, highlighting their role in tissue-device interactions.
From microvesicle-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ARF6 drive microvesicle release? | ARF6 knockout cell line with microvesicle quantification |
| Does RhoA GTPase activity regulate microvesicle budding? | RhoA point-mutation knock-in cells |
| Can microvesicle-transferred mitochondria activate cGAS-STING? | cGAS or STING knockout macrophages |
| Does P-glycoprotein transfer confer drug resistance? | P-glycoprotein overexpression in recipient cells |
| Can microvesicle release be tracked in real time? | Tagged knock-in of microvesicle marker proteins |
| Does microvesicle cargo change under shear stress? | Microfluidic shear-stress model with microvesicle profiling |
How to Study the microvesicle Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Differential centrifugation | Microvesicle enrichment | Isolation from conditioned media |
| Nanoparticle tracking analysis | Size and concentration | Distinguishing microvesicles from exosomes |
| Electron microscopy | Morphology and size | Visualizing microvesicles |
| Mass spectrometry | Protein cargo | Biomarker discovery |
| Western blotting | Specific protein markers | Validating microvesicle preparations |
| Microfluidic shear stress | Release dynamics | Mechanobiology studies |
| Live-cell imaging | Uptake and trafficking | Functional reprogramming assays |
Isolation and Characterization of Microvesicles
Microvesicles are typically isolated by differential centrifugation, size-exclusion chromatography, or affinity capture, and characterized by nanoparticle tracking analysis, electron microscopy, and Western blotting for specific markers. These methods distinguish microvesicles from exosomes based on size and membrane origin.
Proteomics and Cargo Analysis
Mass spectrometry-based proteomics identifies microvesicle cargo and biogenesis regulators, as demonstrated in studies of multidrug resistance. Proteomic profiling can reveal disease-specific signatures for biomarker discovery.
Functional Uptake and Reprogramming Assays
Recipient cells can be treated with isolated microvesicles to test functional reprogramming, such as cGAS-STING activation or metabolic changes. These assays link microvesicle cargo to downstream signaling.
Imaging and Mechanobiology
Live-cell imaging and microfluidic systems measure microvesicle release, uptake, and mechanotransduction under controlled shear stress. These approaches reveal dynamic regulation of microvesicle biology.
How CRISPR Can Be Used to Study GO:1990742 microvesicle
Knockout
CRISPR knockout of genes such as ARF6, RhoA, or cGAS enables loss-of-function studies to test their causal role in microvesicle biogenesis and function. Knockout cell lines can be used to quantify microvesicle release and cargo composition.
Point Mutation
Point mutations can be introduced to dissect specific domains or catalytic activities, such as RhoA GTPase function, without eliminating the protein. These models help distinguish scaffolding from enzymatic roles in microvesicle release.
Knock-in
Knock-in of tagged or reporter alleles allows real-time tracking of microvesicle markers and cargo in live cells. Reporter knock-ins can also monitor cGAS-STING activation upon microvesicle uptake.
Overexpression
Overexpression of candidate genes such as P-glycoprotein or ARF6 can test sufficiency for microvesicle-mediated phenotypes like drug resistance. Overexpression models are useful for gain-of-function screens.
How EDITGENE Supports microvesicle Research
Researchers studying microvesicle-related genes often need to determine whether a candidate gene is causally involved in microvesicle biogenesis, cargo selection, or uptake. EDITGENE provides CRISPR-based cell models and screening services to accelerate this causal dissection.
Contact EDITGENE today to design your custom CRISPR model for microvesicle research.
Frequently Asked Questions About microvesicle
What is GO:1990742 microvesicle?
GO:1990742 microvesicle is a cellular component term for an extracellular vesicle released from the plasma membrane and ranging in size from about 100 nm to 1000 nm.
What genes are involved in microvesicle biogenesis?
Genes such as ARF6, RhoA, ROCK, ESCRT components, and flippase/floppase enzymes are implicated in microvesicle biogenesis.
How are microvesicles different from exosomes?
Microvesicles bud directly from the plasma membrane and range from about 100 nm to 1000 nm, whereas exosomes originate from endosomal multivesicular bodies.
What diseases are associated with microvesicles?
Microvesicles are associated with cancer multidrug resistance, sepsis, cardiovascular disease, and Shiga toxin-associated infection.
How can I study microvesicle release in the lab?
Common methods include differential centrifugation, nanoparticle tracking analysis, electron microscopy, proteomics, and live-cell imaging.
What is the role of microvesicles in sepsis?
Microvesicle-transferred mitochondria can trigger cGAS-STING signaling and reprogram macrophage metabolism in sepsis.
Can CRISPR be used to study microvesicles?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of microvesicle-related genes.
What is the size range of microvesicles?
Microvesicles range from about 100 nm to 1000 nm according to the GO definition.
What cargo do microvesicles carry?
Microvesicles can carry proteins, lipids, RNA, and even mitochondria.
How are microvesicles cleared from circulation?
Microvesicles are cleared by phagocytes and other mechanisms, with dynamic release and clearance in the cardiovascular system.
Conclusion
GO:1990742 microvesicle defines a key class of extracellular vesicles that bud from the plasma membrane and mediate intercellular communication in health and disease. Their biogenesis, cargo, and functions are regulated by cytoskeletal, calcium-dependent, and inflammatory pathways, and they are implicated in cancer, sepsis, cardiovascular disease, and infection. CRISPR-based models and multi-omics methods are essential for dissecting microvesicle biology and translating it into biomarkers and therapeutics.
References
- 1. van Niel G et al.. 2018. Shedding light on the cell biology of extracellular vesicles.. Nat Rev Mol Cell Biol 19(4):213-228 PMID: 29339798
- 2. Villysson A et al.. 2017. Microvesicle Involvement in Shiga Toxin-Associated Infection.. Toxins (Basel) 9(11) PMID: 29156596
- 3. Schwager SC et al.. 2020. Mechanobiology of microvesicle release, uptake, and microvesicle-mediated activation.. Curr Top Membr 86:255-278 PMID: 33837695
- 4. Ji T et al.. 2025. Microvesicle-transferred mitochondria trigger cGAS-STING and reprogram metabolism of macrophages in sepsis.. Microbiol Spectr 13(10):e0078125 PMID: 40905697
- 5. Jayasree A et al.. 2024. Microvesicle-eluting nano-engineered implants influence inflammatory response of keratinocytes.. Drug Deliv Transl Res 14(12):3371-3384 PMID: 37985540
- 6. Taylor J et al.. 2019. Proteins Regulating Microvesicle Biogenesis and Multidrug Resistance in Cancer.. Proteomics 19(1-2):e1800165 PMID: 30520565
- 7. Ayers L et al.. 2015. Dynamic microvesicle release and clearance within the cardiovascular system: triggers and mechanisms.. Clin Sci (Lond) 129(11):915-31 PMID: 26359252
- 8. Song R et al.. 2026. Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction.. Proc Natl Acad Sci U S A 123(15):e2510914123 PMID: 41941625
